chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19; patient was treated with PAXLOVID.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Itchiness on neck / mouth / face; Feel weird for 6 days; Sore throat; Watery eye; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), LACRIMATION INCREASED (Watery eye), PRURITUS (Itchiness on neck / mouth / face) and FEELING ABNORMAL (Feel weird for 6 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), LACRIMATION INCREASED (Watery eye) and FEELING ABNORMAL (Feel weird for 6 days). On an unknown date, the patient experienced PRURITUS (Itchiness on neck / mouth / face). On 07-Apr-2021, FEELING ABNORMAL (Feel weird for 6 days) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), LACRIMATION INCREASED (Watery eye) and PRURITUS (Itchiness on neck / mouth / face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.
Hospitalization: 1/14/2023 - 2/2/2023 (19 days) Presentation to the ED: came from Health and Rehabilitation Center.  SOB, AMS, chest pain and confusion.  COVID + date: 1/14/2023 Treatment: no indication for steroid or remdisivir.  Discharge to: deceased on 2/2/2023.  001A21A 3/5/2021 047A21A 4/2/2021
Patient developed erythematous welt and several days of "inconsolable crying and not sleeping" after administration of DTaP (Daptacel) at both the 2-month and 4-month well-child visits.  Because the crying and insomnia lasted for several days, it was not entirely attributed to the vaccine after the first adminstration.  Given the same response after the second administration, this report was made.
Had a seizure 2 days after vaccine. Also said he had used cocaine, lack of sleep and graduated last weekend
Red, swollen, very hot area around shot site, about palm size, lasting about 24 hrs. Followed by 24 hours of itching and swelling. Third day entire area had a mild bruising of entire area, resolved after bruising no more sx. other than repeated headache for next week.
could see under the skin on her ankle and it was all red; She is going crazy with the rash on her legs and scratching it; rash that blossomed / horrific rash / horrific rash, like eczema or psoriasis; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (could see under the skin on her ankle and it was all red), PRURITUS (She is going crazy with the rash on her legs and scratching it) and RASH (rash that blossomed / horrific rash / horrific rash, like eczema or psoriasis) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (could see under the skin on her ankle and it was all red), PRURITUS (She is going crazy with the rash on her legs and scratching it) and RASH (rash that blossomed / horrific rash / horrific rash, like eczema or psoriasis). The patient was treated with TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE (GLUCOCORTICOID)) in December 2021 at an unspecified dose and frequency. At the time of the report, ERYTHEMA (could see under the skin on her ankle and it was all red), PRURITUS (She is going crazy with the rash on her legs and scratching it) and RASH (rash that blossomed / horrific rash / horrific rash, like eczema or psoriasis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy kidney: (Negative) Negative.         No concomitant medications were reported. she had tried some holistic stuff after getting the booster shot because she developed a horrific rash, like eczema or psoriasis. she only has one kidney. HCP reported that going to back in Jan to have the laser done.  She went to a dermatologist and had all kinds of tests performed.  she went to an allergist as well and everything was negative.  Patient did holistic thing with coconut oil and aloe, but the rash still flares up. She did not take any medications at all.  She saw something about Cibinqo and its not a steroid it was a pill for shingles or something.Cibinqo product has not been prescribed to patient.  she had a light treatment. She also tried, Triamcinolone Acetonide Cream 0.1%: It was a steroid, it worked to a degree but when the rash blossoms it makes her skin thin, and she can't use it all the time. NDC: 45802-064-36, She filled it ages ago in Dec 2021, she used it sparingly.
He had an outbreak of shingles on his face.; This is a spontaneous report from a contactable consumer (patient himself) via medical information team. This 51-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 14Apr2021 as dose 1 single for COVID-19 immunisation at Hospital/workplace clinic dining room. The patient medical history included started drinking alcohol again and stress at work (He was under stress from work and started drinking alcohol again and was stressed out). The patient's concomitant medications were not reported. The patient experienced outbreak of shingles on his face on 22Apr2021. It continued passed the 3 weeks, so he cancelled his second dose. Patient stated he did not report this following the first dose because he was under stress from work and started drinking alcohol again and was stressed out. He didn't think it was related to the vaccine. The outcome of event was unknown.  Information about lot/batch number has been requested.
she experienced tingling on the right side of her face.; Then she said her eye was twitching very slightly; small degree of numbness on her right side of the face; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EN5318) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "penicillin" (unspecified if ongoing), notes: verbatim: She is allergic to penicillin. Concomitant medication(s) included: SYNTHROID. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "she experienced tingling on the right side of her face."; MUSCLE TWITCHING (non-serious), outcome "unknown", described as "Then she said her eye was twitching very slightly"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "small degree of numbness on her right side of the face".  Additional Information: About 15 minutes or so after receiving the Covid vaccine, (Name) told me she experienced tingling on the right side of her face. Then she said her eye was twitching very slightly, with maybe a small degree of numbness on her right side of the face.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician, referring to a 66 year old female patient with osteoporosis (since an unknown date). The patient's medical history was not reported. None concomitant therapies or drug reactions/allergies were reported. On 27-APR-2017, the patient was vaccinated with PNEUMOVAX23 lot # N003993, expiration date on 20-OCT-2018 (strength, dose, anatomical location and administration route were not reported) for prophylaxis. On 28-APR-2017, the patient was seen at the office for treatment of "severe swelling, and redness" to the" injection site and the entire arm." The patient received treatment with BENADRYL, KENALONG injection, REFLEX 500 mg every 6 hours, and prednisone (manufacturer unknown) 40 mg for 7 days. Approximately on 30-APR-2017 (reported as "2 days after treatment started"), the patient stated that she was better. It was reported that no lab diagnostics studies were performed. The reporting physician requested a lot check on this product. The causality between the vaccination with PNEUMOVAX23 and the events was not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Adverse events from the vaccine; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse events from the vaccine), FATIGUE (Tired) and HEADACHE (Headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Transplant (Patient had Kidney Pancreas Transplant from type 1 diabetes). Concurrent medical conditions included Kidney failure, Blood pressure (High blood pressure), Cholesterol, Glaucoma, Neuropathy, Anxiety, Back pain (Lower Back Pain), Arthritis, Type 1 diabetes mellitus and Migraine. Concomitant products included TACROLIMUS, MYCOPHENOLIC ACID, PREDNISONE, OMEPRAZOLE, METOPROLOL TARTRATE, SIMVASTATIN, GABAPENTIN, SERTRALINE HYDROCHLORIDE (ZOLOFT), ONDANSETRON, BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET), METOCLOPRAMIDE, LORAZEPAM and LATANOPROST for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse events from the vaccine), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, VACCINATION COMPLICATION (Adverse events from the vaccine), FATIGUE (Tired) and HEADACHE (Headache) had resolved.            Patient stated that she is a transplant patient who takes immunosuppressants.  Concomitant medication including Vitamins was reported.  No  treatment information was provided.
Pt recvd vax 19SEP92; On 27MAR92 pt recvd 2nd HIB/DTP/OPV & 7 days p/immun pt dx w/Haemophilus type B meningitis;
This patient was given afluria which is only to be given to 18 and older. no reaction. I-92579218 and I-92318744
pt recvd DTP in PM, woke up that eve w/unconsolable crying (high pitched, agitated crying) that persisted for 1 hr; mom also noted temp inc; MD said no pertussis w/next immun;
Pt came to clinic for day 3 RPtP. Reports muscle aches after day 0 shot. Day 3 RABAVERT shot given (L) deltoid without issue pt. took well. Approx. 2 hrs. later pt. called in to report (L) arm, finger and up to cheek cold, tingling, fell asleep. Advised to call her MD. As of 6/29/16- pt. states has some feeling in (L) arm, Not worse, MD advised to go to ER if gets worse. Pt to receive monitoring at hosp. ER in controlled setting.
Patient came to receive her third dose of MODERNA. After being vaccinated, instead of waiting 15 minutes sitting, she went to walk around the store. Feeling dizzy, she went to sit with her mother. She waited an additional 10 minutes sitting down and then she left with her parents because she felt fine.
I had no adverse event following the vaccine. I began not feeling well with upset stomach, congestion and just not feeling well. My whole family was sick, and I was the last one to test positive for COVID-19 on 03/16/2023. I contacted my doctor and told her I tested positive, and she said let them know if I got worse. I took over the counter medication to help with my symptoms. As of today, I continue to have sinus pressure and a sore throat, but I test negative for COVID-19. I previously tested positive for COVID-19 in 04/2022.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20May2023 at 11:00 as dose 5 (booster), single (Lot number: Gj6743) at the age of 71 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hyperthyroid" (unspecified if ongoing), notes: now with treatment hypothyroid; "hyper cholesterolemia" (unspecified if ongoing); "depression" (unspecified if ongoing); "enlarged prostate" (unspecified if ongoing); "sinus congestion" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken (Paxlovid) as a result of drug ineffective, covid-19.
AE(s) following prior vaccinations: Nothing outside the normal of a sore arm or headachy from time to time, but nothing longer than 24hrs; AE(s) following prior vaccinations: Nothing outside the normal of a sore arm or headachy from time to time, but nothing longer than 24hrs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 16Mar2021 as dose 2, single (Lot number: EN6205) at the age of 69 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: She was on statins, notes: She was on statins but she hasn't been on them. Vaccination history included: BNT162b2 (Dose 1; Lot number: EN5318), administration date: 21Feb2021, when the patient was 69-year-old, for COVID-19 Immunization, reaction(s): "AE(s) following prior vaccinations: Nothing outside the normal of a sore arm or headachy from time to time, but nothing longer than 24hrs", "AE(s) following prior vaccinations: Nothing outside the normal of a sore arm or headachy from time to time, but nothing longer than 24hrs". The following information was reported: PAIN IN EXTREMITY (non-serious), HEADACHE (non-serious) all with onset 2021, outcome "recovered" (2021) and all described as "AE(s) following prior vaccinations: Nothing outside the normal of a sore arm or headachy from time to time, but nothing longer than 24hrs".
bad stomach; had stomach pain; heartburn; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL DISCOMFORT (bad stomach), ABDOMINAL PAIN UPPER (had stomach pain) and DYSPEPSIA (heartburn) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M201) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ATORVASTATIN for Cholesterol, OMEPRAZOLE, PROBIOTICS NOS and FAMOTIDINE for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (bad stomach), ABDOMINAL PAIN UPPER (had stomach pain) and DYSPEPSIA (heartburn). At the time of the report, ABDOMINAL DISCOMFORT (bad stomach), ABDOMINAL PAIN UPPER (had stomach pain) and DYSPEPSIA (heartburn) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound abdomen: inconclusive (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include blood pressure medication. No treatment medications was reported.
Received 1st shot on 3/4/2000, flew to Tucson and was sick when I arrived. Flew home on 3/18/2000 and received 2nd shot. Went to private DR on 3/30/2000 and was dx'd with Bronchitis and returned to DR on 4/11/2000, due to no change in condition. Received chest x-ray and more medicines.
Immediately after administration of Tdap, patient c/o dizziness then had loss of consciousness and and jerking/ seizure like movements. Ammonia inhalent used, consciousness regained. While transferring in wheelchair, loss of consciousness occurred again.  Ammonia inhalent used, consciousness regained. VS: B/P-104/68 P-52. Gingerale and crackers given, able to tolerate. VS rechecked 15 mins later: B/P- 110/68 P-72. Pt discharged home with parents.
On the morning of 10/05/21 I woke up with a 99.8 degree fever, slight headache and occasional light cough. I went to clinic at 10:00 for a scheduled medical checkup. I notified them before going that I had these systems. When I arrived they chose to test me for Covid-19 and it came back positive. They prescribed a five day dose of Azithromycin 250mg, five day Dexamethason 6mg and tylenol as needed for fever. I also received the IV treatment of bamlanivimab and etesevimab on 10/05 at 5:20pm. My headache and fever had already went away before the treatment was given.
SORE ARM; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced sore arm. On APR-2021, the subject experienced mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm and mild headache was not reported. This report was non-serious.
PATIENT GOT A FEVER, REDNESS AROUND THE VACCINE AREA. HARDNESS ON THE INJECTION SITE, JOINT PAIN, FATIGUE AND NAUSEA AND VOMITING. PATIENT STATES THAT IT IS NOW CURRENTLY GETTING BETTER.
This case was reported by a consumer call via call center representative and described the occurrence of allergic reaction in a 71-year-old female patient who received BOOSTRIX (batch number 3457Y, expiry date 20th May 2019). The patient's past medical history included Lyme disease. Concurrent medication conditions included penicillin allergy, allergic reaction to antibiotics (in 2002) and allergic reaction to analgesics. Concomitant products included atorvastatin, BENICAR, CYMBALTA, metformin, TRAVATIN Z and Aspirin (Baby).  On 28th April 2017 13:00, the patient received the 1st dose of BOOSTRIX (intramuscular) .5 ml. On 8th May 2017, 10 days after receiving BOOSTRIX, the patient experienced allergic reaction, pruritus, swelling arm, rash and vaccination site discharge. The patient was treated with prednisone. On an unknown date, the outcome of the allergic reaction, pruritus, swelling arm, rash and vaccination site discharge were not recovered/not resolved. The reporter considered the allergic reaction, pruritus, swelling arm, rash and vaccination site discharge to be almost certainly related to BOOSTRIX. Additional details were provided as follows: The patient had no previous reactions to vaccines and no rubber or latex allergies. The patient received BOOSTRIX in his left arm. The patient went to visit her daughter out of town. Within 10 days of receiving the vaccine, the patient had a rash with some oozing spots. The patient required an emergency room visit. The patient went to a walk-in clinic and was prescribed prednisone and anti-itch and a cream. The condition was improving, but on the day of reporting there was some new spots. The home where the patient was visiting had new bedding, but the patient felt that the vaccine was the cause of the rash. The patient was returning home next day of reporting and would consult with her primary physician.
Fiery red spot approximately two inches across at the site of injection. This started ten days after vaccination. It stung and itched. It was very uncomfortable. It still stings but it looks and feel much better better now. I called my family doctor, they said report it to the health department. I called they said report to Moderna.
pt recv vax & approx 6 days later pt devel golf ball size swelling @ the inj site;
Hot flushed itchy throat monitored vitals provided fluids vials stable pt monitored for an additional 40 min Sx resolved pt ok to leave
nausea; Subjective fever; chills; shaking; significant muscle and joint pain; significant muscle and joint pain; fatigue; headache; This is a spontaneous report from a non-contactable Physician (patient) reported for himself. This 32-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9264, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 28Jan2021 at 09:00 am (age at vaccination was 32 years) as 2ND DOSE, SINGLE DOSE for COVID-19 immunization. The patient did not have any medical history. Concomitant medications patient received within 2 weeks of vaccination included ibuprofen (MOTRIN [IBUPROFEN]), acetylsalicylic acid, caffeine, salicylamide (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) as needed. The patient previously took augmentin [amoxicillin;clavulanic acid] and had allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EK9231, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 07Jan2021 at 11:00 am (age at vaccination was unknown) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Hospital. On an unknown date, the patient experienced subjective fever, chills, shaking, significant muscle and joint pain, fatigue, headache, nausea which started 18 hours after injection. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.